XML 35 R26.htm IDEA: XBRL DOCUMENT
v3.23.1

Investments (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2023
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Investments | Equity investments by measurement category were as follows (in thousands):
Measurement category | March 31, 2023 |  | June 30, 2022
Fair value | $ | 12,115 |  |  | $ | 9,167 |
Measurement alternative | 70,640 |  |  | 39,290 |
Equity method | 67,697 |  |  | 9,918 |
Total | $ | 150,452 |  |  | $ | 58,375 |
Schedule of Changes in Equity Investments | The following tables show a reconciliation of the changes in our equity investments (in thousands):
| Nine Months Ended March 31, 2023
| Non-marketable securities |  | Marketable securities |  | Equity method investments |  | Total
Balance at the beginning of the period | $ | 39,290 |  |  | $ | 9,167 |  |  | $ | 9,918 |  |  | $ | 58,375 |
Additions to investments (1) | 21,738 |  |  | 4,991 |  |  | 60,233 |  |  | 86,962 |
Observable price adjustments on non-marketable equity securities | 12,612 |  |  | — |  |  | — |  |  | 12,612 |
Unrealized losses on marketable equity securities | — |  |  | (2,043) |  |  | — |  |  | (2,043) |
Realized gains on marketable and non-marketable equity securities | 3,937 |  |  | — |  |  | — |  |  | 3,937 |
Proceeds from exits of investments | (3,937) |  |  | — |  |  | — |  |  | (3,937) |
Impairment of investments | (3,000) |  |  | — |  |  | — |  |  | (3,000) |
Loss attributable to equity method investments | — |  |  | — |  |  | (5,037) |  |  | (5,037) |
Foreign currency translation adjustments | — |  |  | — |  |  | 2,583 |  |  | 2,583 |
Carrying value at the end of the period | $ | 70,640 |  |  | $ | 12,115 |  |  | $ | 67,697 |  |  | $ | 150,452 |
(1)Includes additions from purchases and an equity method investment acquired and measured at fair value via our acquisition of MEDIFOX DAN. Refer to Note 12 herein.
| Nine Months Ended March 31, 2022
| Non-marketable securities |  | Marketable securities |  | Equity method investments |  | Total
Balance at the beginning of the period | $ | 23,002 |  |  | $ | 29,084 |  |  | $ | 17,154 |  |  | $ | 69,240 |
Net additions (reductions) to investments (2) | 7,665 |  |  | (3,202) |  |  | 1,250 |  |  | 5,713 |
Observable price adjustments on non-marketable equity securities | 5,367 |  |  | — |  |  | — |  |  | 5,367 |
Unrealized losses on marketable equity securities | — |  |  | (9,666) |  |  | — |  |  | (9,666) |
Realized gains on marketable and non-marketable equity securities | 2,355 |  |  | 1,626 |  |  | — |  |  | 3,981 |
Impairment of investments | (209) |  |  | — |  |  | — |  |  | (209) |
Loss attributable to equity method investments | — |  |  | — |  |  | (5,927) |  |  | (5,927) |
Carrying value at the end of the period | $ | 38,180 |  |  | $ | 17,842 |  |  | $ | 12,477 |  |  | $ | 68,499 |
(2)Includes additions from purchases, reductions due to exits of securities, or reclassifications due to our acquisition of an investee in which we held a prior equity interest.

X
- Definition Schedule Of Changes In Equity Investments [Table Text Block] + References No definition available. + Details
Name: | rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock
Namespace Prefix: | rmd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Investments [Table Text Block] + References No definition available. + Details
Name: | rmd_ScheduleOfInvestmentsTableTextBlock
Namespace Prefix: | rmd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration